CME Programme
-
Non-Regular Activities
Patient Identification and Treatment Initiation with Abemaciclib for HR+ HER2- Breast CancerDate: 22/06/2023 Enquiries: Eli Lilly Asia Inc CME Points Awarded: 1 point
CME Programme
Date: | 22/06/2023 |
Enquiries: | Eli Lilly Asia Inc |
CME Points Awarded: | 1 point |